1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow PARP Inhibitor: new trials by email Literature Review of PARP Inhibitor trials Research Report on PARP Inhibitor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients Olaparib, Temozolomide (TMZ), IMRT (Intensity Modulated Radiation Therapy) - Malignant Gliomas, Radiotherapy | Phase 1 / Phase 2 | Active not recruiting | Centre Francois Baclesse | 91 | 2017-09-04 | 2025-12-04 |
Glioma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1)
Radiotherapy, Intensity-Modulated (1) · Temozolomide (1) · olaparib (1)
France (1)